Recombinant Human Mammary Serine Protease Inhibitor (rHuMaspin)

Official Full Name

Recombinant Human Mammary Serine Protease Inhibitor (rHuMaspin)

Synonyms

SerpinB5, Protease Inhibitor 5

Squence

Squence of Recombinant Human Mammary Serine Protease Inhibitor

Amino Acid Sequence

MDALQLANSA FAVDLFKQLC EKEPLGNVLF SPICLSTSLS LAQVGAKGDT ANEIGQVLHF ENVKDIPFGF QTVTSDVNKL SSFYSLKLIK RLYVDKSLNL STEFISSTKR PYAKELETVD FKDKLEETKG QINNSIKDLT DGHFENILAD NSVNDQTKIL VVNAAYFVGK WMKKFPESET KECPFRLNKT DTKPVQMMNM EATFCMGNID SINCKIIELP FQNKHLSMFI LLPKDVEDES TGLEKIEKQL NSESLSQWTN PSTMANAKVK LSIPKFKVEK MIDPKACLEN LGLKHIFSED TSDFSGMSET KGVALSNVIH KVCLEITEDG GDSIEVPGAR ILQHKDELNA DHPFIYIIRH NKTRNIIFFG KFCSP

Synonyms

SerpinB5, Protease Inhibitor 5

Accession

P36952

Gene ID

5268

Summary

Source

Escherichia coli.

Molecular Weight

Approximately 42.1 kDa, a single non-glycosylated polypeptide chain containing 375 amino acid residues.

Biological Activity

No data available

Appearance

Sterile filtered white lyophilized (freeze-dried) powder.

Formulation

Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4.

Endotoxin

Less than 1 EU/ug of rHuMaspin as determined by LAL method.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution.

References

1. Goulet B, Kennette W, Ablack A, et al. 2011. Lab Invest, 91: 1181-7.2. Schwarz S, Ettl T, Kleinsasser N, et al. 2008. Oral Oncol, 44: 563-70.3. Abd El-Wahed MM. 2005. J Egypt Natl Canc Inst, 17: 173-83.4. Katakura H, Takenaka K, Nakagawa M, et al. 2006. Lung Cancer, 51: 323-8.

Purity

> 95 % by SDS-PAGE and HPLC analyses.

SDS-PAGE

SDS-PAGE of Recombinant Human Mammary Serine Protease Inhibitor

Pack Size

5ug/100ug/500ug

Safety Data Sheet (SDS) Download

Click to download

Technical Data Sheet (TDS) Download

Click to download

Links

This product is branded by ChemWhat and sold through our website and here is the corresponding link Recombinant Human Mammary Serine Protease Inhibitor (rHuMaspin) on ChemWhat